XT - ETF AI Analysis
Top Page
iShares Exponential Technologies ETF (XT)
XT’s rating suggests it is a solid but not top-tier ETF, driven largely by strong, diversified leaders like Microsoft, Texas Instruments, Nvidia, and Johnson & Johnson, which benefit from robust financial performance and growth in areas such as cloud, AI, and advanced semiconductors. The fund’s score is held back somewhat by holdings like CrowdStrike and Amazon, where valuation and profitability or cash flow challenges introduce caution. A key risk factor is its heavy focus on high-growth technology names, which can mean higher volatility and sensitivity to market sentiment.
XT vs. SPDR S&P 500 ETF (SPY)
- AUM
- 3.96B
- Region
- Global
- Expense Ratio
- 0.46%
- Beta
- 1.10
- Issuer
- iShares
- Inception Date
- Mar 19, 2015
- Dividend Yield
- 6.81%
- Asset Class
- Equity
- Index Tracked
- Morningstar Exponential Technologies Index
XT Summary
The iShares Exponential Technologies ETF (XT) tracks the Morningstar Exponential Technologies Index, focusing on companies using cutting-edge tools like robotics, artificial intelligence, and advanced healthcare technology. It holds many U.S. stocks and mixes tech and health care names, including well-known companies like Microsoft, Nvidia, Amazon, and Eli Lilly. Someone might invest in XT to seek long-term growth and diversify across many innovative businesses in one fund. A key risk is that it’s heavily tied to technology and future-focused companies, so its price can be more volatile and can go up and down sharply with market sentiment.
How much will it cost me?
The iShares Exponential Technologies ETF (XT) has an expense ratio of 0.46%, meaning you’ll pay $4.60 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed to focus on innovative and emerging technologies, which require more research and specialized expertise.
What would affect this ETF?
The iShares Exponential Technologies ETF (XT) could benefit from continued advancements in technology, such as artificial intelligence and robotics, which are driving innovation across industries globally. However, it may face challenges from rising interest rates, which can impact growth-focused companies, and potential regulatory changes affecting key sectors like healthcare and technology. Its global exposure and diversified holdings provide resilience, but economic slowdowns or geopolitical tensions could negatively affect its performance.
XT Top 10 Holdings
XT is leaning heavily into U.S.-centric, next‑gen tech, with semiconductor names like Texas Instruments, Nvidia, and Analog Devices doing much of the heavy lifting as their shares keep rising. Cybersecurity stars Palo Alto Networks and CrowdStrike are also powering ahead, giving the fund a strong AI and digital-defense flavor. On the flip side, Tesla is dragging the ETF, with its recent performance losing steam, while Eli Lilly and Amazon look more mixed. Overall, the fund is globally themed but practically anchored in American innovation and exponential technologies.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 4.34% | $173.59M | $1.21T | 58.93% | 72Outperform | |
| Microsoft | 4.19% | $167.46M | $3.95T | 2.95% | 79Outperform | |
| Texas Instruments | 4.27% | $170.44M | $253.68B | 57.40% | 78Outperform | |
| Tesla | 4.29% | $171.37M | $1.53T | -12.68% | 73Outperform | |
| Nvidia | 3.79% | $151.29M | $5.22T | 22.53% | 76Outperform | |
| Palo Alto Networks | 3.22% | $128.84M | $278.35B | 61.96% | 73Outperform | |
| Analog Devices | 3.22% | $128.81M | $192.40B | 64.78% | 78Outperform | |
| Johnson & Johnson | 2.94% | $117.60M | $621.22B | 34.34% | 78Outperform | |
| Amazon | 2.76% | $110.16M | $2.83T | 18.17% | 71Outperform | |
| AbbVie | 2.47% | $98.53M | $510.84B | 23.08% | 66Neutral |
XT Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XT, the sentiment is Positive. The current price of 83.53 is below the 20-day moving average (MA) of 83.76, above the 50-day MA of 82.95, and above the 200-day MA of 77.47, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 51.51 is Neutral, neither overbought nor oversold. The STOCH value of 35.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XT.
XT Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $83.53 | $92.00(10.14% Upside) | $3.96B | 0.46% | 69Neutral | |
| $54.17 | $60.78(12.19% Upside) | $7.10B | 0.46% | 59Neutral | |
| $76.38 | $85.81(12.35% Upside) | $5.40B | 0.40% | 64Neutral | |
| $122.21 | $135.52(10.89% Upside) | $3.35B | 0.60% | 68Neutral | |
| $125.61 | $158.36(26.07% Upside) | $3.25B | 0.65% | 64Neutral | |
| $63.50 | $73.94(16.44% Upside) | $3.01B | 0.47% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| XT | iShares Exponential Technologies ETF | 83.53 | 15.07 | 22.01% | |
| GUNR | FlexShares Morningstar Global Upstream Natural Resources Index Fund | 54.17 | 11.27 | 26.26% | |
| GNR | SPDR S&P Global Natural Resources ETF | 76.38 | 18.46 | 31.87% | |
| HACK | Etfmg Prime Cyber Security Etf | 122.21 | 34.85 | 39.90% | |
| FWD | AB Disruptors ETF | 125.61 | 20.78 | 19.83% | |
| NFRA | FlexShares STOXX Global Broad Infrastructure Index Fund | 63.50 | 3.96 | 6.65% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.